Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
On CNBC's Fast Money Final Trade, Tim Seymour said that Gilead Sciences, Inc. (NASDAQ: GILD) looks cheap at 7 times price-to-earnings multiple. He sees it as a relative value and the best way to play the sector.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Steve Grasso would buy iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) and Pfizer Inc. (NYSE: PFE).
Guy Adami said IBB bounced off $240 on Monday, and now he believes that the risk reward sets up really well for the stock. He added that politicians haven't been talking about biotech companies for a couple of weeks.